AI Strategy ROI: What IQVIA Teaches Singapore Firms

A six-day selloff that erased nearly US$830 billion from software and services stocks doesn’t happen because investors suddenly hate technology. It happens when they’re not convinced the value is real—or durable.

That’s the backdrop for IQVIA’s latest earnings call (reported by Reuters via CNA), where analysts pushed hard on a question that’s now hitting boardrooms everywhere: If new AI tools keep getting better, do they replace parts of your business? IQVIA’s CEO wasn’t having it, calling the fear “really frustrating” and arguing their proprietary healthcare data assets become more valuable, not less.

For Singapore leaders following the AI Business Tools Singapore series, this is more than an overseas corporate drama. It’s a clean case study in how serious enterprises defend AI investment—while the market demands proof. If you’re in ops, marketing, or customer experience, the lesson is simple: AI strategy isn’t judged by how advanced your models are. It’s judged by whether it changes business outcomes you can measure.

What happened at IQVIA—and why it matters in Singapore

IQVIA defended its AI strategy after forecasting 2026 adjusted earnings of US$12.55–US$12.85 per share, below analysts’ average estimate of US$12.95 (per LSEG, reported in the article). Shares fell over 8% in late morning trading. The company also flagged nearly US$80 million in higher interest expenses as a drag.

Here’s the key point: this wasn’t an “AI is bad” story. It was an “AI must prove impact” story.

The analyst concern: AI can commoditise services

Investors have seen generative AI vendors (and increasingly capable agents) creep into work that used to justify premium fees—research, analysis, content production, coding assistance, even parts of consulting delivery.

So analysts asked a blunt question: if general-purpose AI can do more, does it displace what IQVIA sells?

That question maps cleanly to Singapore’s service-heavy economy:

• Professional services firms worry about AI doing junior analyst work.
• B2B sales teams worry about AI rewriting outreach and reducing “agency value.”
• Ops teams worry automation makes parts of back-office work redundant.

Most companies get this wrong: they respond with broad slogans (“we’re an AI-first business”) instead of a defensible, numbers-backed story.

IQVIA’s answer: unique data + workflow integration wins

IQVIA’s CEO argued their proprietary healthcare information assets can’t be replicated by general-purpose models. That’s a strong stance, and it’s the right direction for most businesses.

A practical translation for Singapore companies:

Your moat isn’t the AI model. Your moat is what only you have—data, distribution, trust, and the workflows where decisions happen.

If your AI strategy doesn’t strengthen at least one of those, the market will treat it as a cost centre.

The real debate: “AI adoption” vs “AI advantage”

Plenty of teams can deploy an AI chatbot in a month. Fewer can show it improved customer satisfaction, shortened cycle time, or increased revenue without breaking compliance.

AI adoption is easy to claim—and hard to defend

In 2026, claiming you “use AI” is table stakes. The hard part is answering:

• Which process got faster?
• Which metric moved?
• Which risk went down?
• Which cost stays down after the pilot ends?

In the IQVIA story, the tension wasn’t about whether AI is helpful. It was whether AI changes the competitive landscape enough to pressure pricing or reduce demand.

For Singapore business leaders, this becomes a governance question:

• If AI reduces the perceived value of a service, what do you repackage and reprice?
• If AI increases productivity, how do you convert that into margin or growth (instead of just “busy work faster”)?

A useful definition for decision-makers

AI advantage is when AI creates a sustained improvement in unit economics—higher output per headcount, higher conversion per lead, lower cost-to-serve, or lower risk per transaction.

If you can’t express your AI work in those terms, analysts (or your CFO) will treat it as experimentation.

What Singapore businesses can copy from IQVIA (without being a data giant)

You don’t need “the largest proprietary healthcare information assets in the world” to make AI defensible. You need a tight loop between data, workflow, and measurable outcomes.

1) Build a “proprietary data wedge” from what you already have

Most SMEs and mid-market firms in Singapore have underused proprietary data—just not in a neat warehouse.

Start with datasets that are already close to revenue:

• Sales: lead sources, objections, win/loss notes, deal cycle length
• Marketing: campaign performance by segment, creative variants, landing page behavior
• Customer support: ticket categories, resolution paths, repeat contact reasons
• Operations: turnaround times, exceptions, supplier delays, quality incidents

A practical stance I’ve found works: don’t chase “big data.” Chase “useful data.” A few thousand clean, well-labeled records tied to outcomes can beat a million messy rows.

2) Put AI inside the workflow, not beside it

AI fails when it becomes “another tool tab.” IQVIA’s defense implicitly points to workflow value—AI that is embedded into decision-making and delivery.

For Singapore teams, that means:

• AI-assisted quoting inside your CRM, not in a separate chat window
• Support drafting and next-step suggestions inside your helpdesk
• Ops exception handling integrated into your ERP or ticketing

If your staff has to copy-paste between systems, adoption drops and risk increases.

3) Choose 1–2 metrics that prove business impact

Pick metrics that executives care about and teams can actually influence:

• Marketing: cost per qualified lead (CPQL), lead-to-meeting rate, conversion rate
• Sales: time-to-first-response, pipeline velocity, win rate
• Customer experience: first contact resolution, average handling time, CSAT
• Operations: cycle time, defect rate, exceptions per 100 orders

Then define the “AI claim” in one sentence:

“This AI workflow reduces onboarding time from 5 days to 3 days by automating document checks and drafting responses, with human approval.”

That’s defensible. “We’re implementing AI to improve efficiency” isn’t.

The risk side: what IQVIA’s moment says about governance

When markets get jumpy, they punish vague AI narratives. They also punish avoidable AI risk.

The three AI risks Singapore leaders should plan for

1. Commoditisation risk

   • If your deliverable looks like something a general-purpose AI can generate, your pricing power weakens.
   • Fix: bundle expertise + proprietary context + accountability.

2. Data leakage and compliance risk

   • Regulated industries (finance, healthcare, education) can’t treat public AI tools like harmless writing assistants.
   • Fix: policies, redaction workflows, approved tools, audit trails.

3. Model drift and accountability risk

   • AI outputs change as prompts, data, and processes evolve.
   • Fix: human sign-off for high-stakes tasks, monitoring, clear ownership.

A quote-worthy internal rule: If an AI decision can cost you money or reputation, it needs an owner and an audit trail.

Practical playbook: turning “analyst skepticism” into a stronger AI roadmap

If you’re building an AI roadmap for marketing, operations, or customer engagement, here’s a structure that tends to survive scrutiny.

Step 1: Identify your “replaceable” work

Make a list of outputs that could be copied by a competitor using generic AI:

• Basic reports and summaries
• Generic ad copy and blog drafts
• Simple customer replies
• Routine data cleanup

Then decide what you’ll do:

• Automate it (and redeploy people to higher-value work), or
• Productise it (bundle into a paid service with clear scope), or
• Differentiate it (add proprietary benchmarks, vertical expertise, or guarantees)

Step 2: Define your differentiation layer

This is the IQVIA lesson: protect what’s unique.

Examples for Singapore companies:

• Local compliance know-how (PDPA workflows, sector guidelines)
• Singapore/SEA-specific customer language patterns and buying behavior
• Proprietary benchmarks (e.g., average response times by industry)
• Unique distribution (partner channels, communities, installed base)

Step 3: Pilot fast, but with a measurement contract

A good pilot includes:

• Baseline metrics (before)
• Target improvement (after)
• Timebox (e.g., 4–6 weeks)
• Risk controls (what data can/can’t be used)
• “Kill criteria” (when you stop)

This avoids the most common failure pattern: pilots that “feel promising” but never land.

Where this leaves Singapore in early 2026

The market mood captured in the IQVIA story—AI optimism paired with ROI anxiety—is exactly what I’m seeing in Singapore conversations: leaders want AI business tools, but they don’t want another initiative that produces demos instead of results.

The reality? It’s simpler than you think. AI is valuable when it increases throughput, improves decisions, or lowers cost-to-serve—while keeping governance tight. That’s the standard analysts are applying to IQVIA, and it’s the standard your leadership team will apply to you.

If you’re planning your next quarter, treat IQVIA’s moment as a prompt: Can you defend your AI roadmap in one page, with numbers? If not, your next step isn’t another tool. It’s a clearer measurement plan and a tighter tie to proprietary business context.

What would change in your business if you could point to one workflow and say, “AI made this faster, safer, and measurably cheaper”—and you could prove it?